Application of liquid chromatography/mass spectrometry and nuclear magnetic resonance to the identification of degradates of a novel insulin sensitizer in aqueous solutions.
Degradation of a novel insulin sensitizer in aqueous solutions was studied using high pressure liquid chromatography/mass spectrometry (LC/MS). The insulin sensitizer, containing a thiazolidine-2,4-dione (TZD), was a new class of antidiabetic agent for the treatment of type II diabetes. Chemical stability of the insulin sensitizer was evaluated by stressing its aqueous solutions at 40 degrees C for 24 h. Oxygen was removed from one of the solutions by bubbling pure nitrogen through to identify non-oxidative pathways. LC/MS analyses of the stressed solutions revealed that hydrolysis and oxidation are the primary degradation pathways for the studied compound. A alpha-thiol acetic acid, acyl amide, and two dimeric diastereomers were the main degradates of the insulin sensitizer. The alpha-thiol acetic acid served as an intermediate-like species, and oxidized to two dimeric degradates upon exposing to air. All of them were identified as ring-opening products of the TZD. The entities of the acyl amide and dimeric degradates were respectively verified by a synthetic standard or NMR following isolation of a diastereomeric degradate. Characterization using MS in both positive and negative ion scans were discussed for an isolated diastereomeric degradate. Mechanisms of fragmentation and formation for those degradates are presented based on the MS result.
Wang
Michael H
MH
Merck Research Laboratories, Sumneytown Pike, P.O. Box 4, WP 14-2E, West Point, PA 19486, USA. hongmike_wang@merck.com
Wu
Yunhui
Y
Hwang
Tsang-Lin
TL
Qin
Xue-Zhi
XZ
Karki
Shyam
S
Treemaneekarn
Varaporn
V
D002851:Chromatography, High Pressure Liquid; D007004:Hypoglycemic Agents / Q000032:analysis*; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D012996:Solutions; D013056:Spectrophotometry, Ultraviolet; D045162:Thiazolidinediones / Q000032:analysis*; D014867:Water
D007004:Hypoglycemic Agents; D012996:Solutions; D045162:Thiazolidinediones; D014867:Water; C089946:2,4-thiazolidinedione